We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » E.U.'s NEW DRUG LAW TOUGHENS DATA EXCLUSIVITY, DELAYS GENERICS
E.U.'s NEW DRUG LAW TOUGHENS DATA EXCLUSIVITY, DELAYS GENERICS
January 13, 2004
The European Parliament last month voted to give brand firms up to 11 years of exclusivity on products before they would have to face generic competition, a move that European generic drug advocates say could delay generic entry but will also provide for a more efficient regulatory system.